Potential life-saving treatment for one type of leukemia
LHI researcher Rita Perlingeiro, Ph.D. has dicovered a potential life-saving treatment for acute myeloid leukemia (AML) using a designed antibody to block the activity of endoglin in the cancer cells.
In Memoriam: Dr. Alan T. Hirsch
In memory of Dr. Alan T. Hirsch - Professor of Medicine, Epidemiology, and Community Health and leader in the Medical School's Vascular Medicine Program.
Beloved professor, colleague, mentor, and friend
Jop van Berlo Awarded King Asst. Professorship
Jop van Berlo, M.D., Ph.D has been awarded the Lois and Richard King Assistant Professorship in the Department of Medicine. This position is awarded based on scholarly inquiry and academic success in basic science research. The award is $50k/yr until the holder is promoted to associate professor.
The Lillehei Heart Institute brings together faculty and students committed to cardiovascular scholarship, facilitating their interaction and allowing them to share core University resources.
Financial support from the Institute provides the margin of excellence that enhances our competitiveness in the global effort to cure heart and vascular diseases.
The Institute is built on the legacy of University of Minnesota icons that created a culture of innovation and discovery. Today, established investigators who have secured highly competitive federal, corporate and foundation research grants working together with the next generation of young investigators to lessen the toll of cardiovascular disease on all of us.
LHI researcher Rita Perlingeiro, Ph.D.
LHI member Brenda Ogle heas been leading research to create a bio-engineered patch to repair damaged hearts.